Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 12, 2008 - Issue 11
Submit an article Journal homepage
140
Views
11
CrossRef citations to date
0
Altmetric
Review

Challenges in developing targeted therapy for pancreatic adenocarcinoma

Devalingam Mahalingam University of Texas Health Science Centre San Antonio, Institute of Drug Development, Division of Hematology and Medical Oncology, Division of Cancer Research and Therapy Centre, Texas 78229, USA +210 450 1827; +210 450 9823; [email protected]
&
Francis Giles University of Texas Health Science Centre San Antonio, Institute of Drug Development, Division of Hematology and Medical Oncology, Division of Cancer Research and Therapy Centre, Texas 78229, USA +210 450 1827; +210 450 9823; [email protected]
Pages 1389-1401 | Published online: 14 Oct 2008

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Devalingam Mahalingam, Kevin R Kelly, Ronan T Swords, Jennifer Carew, Steffan T Nawrocki & Francis J Giles. (2009) Emerging drugs in the treatment of pancreatic cancer. Expert Opinion on Emerging Drugs 14:2, pages 311-328.
Read now

Articles from other publishers (10)

Andriana Inkoom, Nkafu Bechem Ndemazie, Taylor Smith, Esther Frimpong, Raviteja Bulusu, Rosemary Poku, Xue Zhu, Bo Han, Jose Trevino & Edward Agyare. (2023) Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. BMC Cancer 23:1.
Crossref
Anastasia Tsiaousidou, A. K. Tsaroucha, M. Lambropoulou, M. Pitiakoudis, A. Polychronidis, E. Chatzitheoklitos, K. Romanidis & C. Simopoulos. (2015) Increased B7H4 tissue expression correlates with high CA19.9 serum levels and a worse prognosis of pancreatic adenocarcinoma. Clinical and Experimental Medicine 16:3, pages 351-356.
Crossref
Jiarui Wang, Xuemei Zhang, Danjun Ma, Wai-Nang Paul Lee, Jing Xiao, Yingchun Zhao, Vay Liang Go, Qi Wang, Yun Yen, Robert Recker & Gary Guishan Xiao. (2013) Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells. Experimental Hematology & Oncology 2:1.
Crossref
A. Tsiaousidou, M. Lambropoulou, E. Chatzitheoklitos, G. Tripsianis, C. Tsompanidou, C. Simopoulos & A.K. Tsaroucha. (2013) B7H4, HSP27 and DJ-1 molecular markers as prognostic factors in pancreatic cancer. Pancreatology 13:6, pages 564-569.
Crossref
Murat Yalcin, Hung-Yun Lin, Thangirala Sudha, Dhruba J. Bharali, Ran Meng, Heng-Yuan Tang, Faith B. Davis, Steven C. Stain, Paul J. Davis & Shaker A. Mousa. (2013) Response of Human Pancreatic Cancer Cell Xenografts to Tetraiodothyroacetic Acid Nanoparticles. Hormones and Cancer 4:3, pages 176-185.
Crossref
Kotoe Kashiwaya, Hidewaki Nakagawa, Masayo Hosokawa, Yasuo Mochizuki, Koji Ueda, Lianhua Piao, Suyoun Chung, Ryuji Hamamoto, Hidetoshi Eguchi, Hiroaki Ohigashi, Osamu Ishikawa, Carsten Janke, Yasuhisa Shinomura & Yusuke Nakamura. (2010) Involvement of the Tubulin Tyrosine Ligase-Like Family Member 4 Polyglutamylase in PELP1 Polyglutamylation and Chromatin Remodeling in Pancreatic Cancer Cells. Cancer Research 70:10, pages 4024-4033.
Crossref
Sharmila P. Mehta. (2010) Palliative Chemotherapy for Pancreatic Malignancies. Surgical Clinics of North America 90:2, pages 365-375.
Crossref
Chitta Ranjan Patra, Resham Bhattacharya, Debabrata Mukhopadhyay & Priyabrata Mukherjee. (2010) Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Advanced Drug Delivery Reviews 62:3, pages 346-361.
Crossref
Hengwei ZhangRui CaoWai-Nang Paul LeeCaishu DengYingchun ZhaoJoan LappeRobert ReckerYun YenQi WangMing-Ying TsaiVay Liang GoGary Guishan Xiao. (2010) Inhibition of Protein Phosphorylation in MIA Pancreatic Cancer Cells: Confluence of Metabolic and Signaling Pathways. Journal of Proteome Research 9:2, pages 980-989.
Crossref
Devalingam MahalingamKamalesh SankhalaAlain MitaFrancis J GilesMonica M Mita. (2009) Targeting the mTOR pathway using deforolimus in cancer therapy. Future Oncology 5:3, pages 291-303.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.